ASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spain
dc.contributor.author | Vicente Baz, D. | |
dc.contributor.author | Paredes Lario, A. | |
dc.contributor.author | Moran Bueno, M. T. | |
dc.contributor.author | Massuti Sureda, B. | |
dc.contributor.author | Reguard, N. | |
dc.contributor.author | Alvarez, R. | |
dc.contributor.author | Insa Molla, A. | |
dc.contributor.author | Juan, O. | |
dc.contributor.author | Marquez, G. | |
dc.contributor.author | Provencio Pulla, M. | |
dc.contributor.authoraffiliation | [Vicente Baz, D.] Hosp Univ Virgen Macarena, Seville, Spain | |
dc.contributor.authoraffiliation | [Paredes Lario, A.] Hosp Donostia, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Moran Bueno, M. T.] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Massuti Sureda, B.] Hosp Gen Univ Alicante, Alicante, Spain | |
dc.contributor.authoraffiliation | [Reguard, N.] Hosp Clin Barcelona, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Alvarez, R.] Hosp Gen Univ Gregorio Maranon, Madrid, Spain | |
dc.contributor.authoraffiliation | [Insa Molla, A.] Hosp Clin Univ Valencia, Valencia, Spain | |
dc.contributor.authoraffiliation | [Juan, O.] Hosp Univ & Politecn La Fe, Valencia, Spain | |
dc.contributor.authoraffiliation | [Marquez, G.] AstraZeneca Spain, Madrid, Spain | |
dc.contributor.authoraffiliation | [Provencio Pulla, M.] Hosp Univ Puerta de Hierro Majadahonda, Serv Oncol Med, Madrid, Spain | |
dc.contributor.funder | AstraZeneca | |
dc.date.accessioned | 2025-01-07T16:01:35Z | |
dc.date.available | 2025-01-07T16:01:35Z | |
dc.date.issued | 2018-04-01 | |
dc.identifier.doi | 10.1016/S1556-0864(18)30430-1 | |
dc.identifier.essn | 1556-1380 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.unpaywallURL | http://www.jto.org/article/S1556086418304301/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27572 | |
dc.identifier.wosID | 436557600151 | |
dc.issue.number | 4 | |
dc.issue.number | S | |
dc.journal.title | Journal of thoracic oncology | |
dc.journal.titleabbreviation | J. thorac. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.organization | SAS - Hospital Universitario Virgen Macarena | |
dc.page.number | S93-S94 | |
dc.publisher | Elsevier science inc | |
dc.rights.accessRights | open access | |
dc.title | ASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spain | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 13 | |
dc.wostype | Meeting Abstract |